SlideShare a Scribd company logo
Vital QMS Process Validation Statistics - OMTEC 2018
Vital QMS Process Validation
Statistics
W. Heath Rushing
Principal Consultant
206-369-5541
Heath.Rushing@adsurgo.com
3
Contents
1. Introduction
2. Overview
3. Application of Statistical Methods:
- Installation Qualification (IQ)
- Operational Qualification (OQ)
- Performance Qualification (PQ)
4
Why are you here?
According to the Quality System Regulation (QSR), “Where appropriate,
each manufacturer shall establish and maintain procedures for
identifying valid statistical techniques required for establishing,
controlling, verifying the acceptability of process capability and
product characteristics.” Although there are many statistical methods
that may be applied to satisfy this portion of the QSR, there are some
commonly accepted methods that all companies can and should be
using to develop acceptance criteria, to ensure accurate and precise
measurement systems, to fully characterize manufacturing processes,
to monitor and control process results and to select an appropriate
number of samples.
Overview
6
Statistical Techniques
“Valid in-process specifications for such characteristics shall be consistent
with drug product final specifications and shall be derived from previous
acceptable process average and process variability estimates where
possible and determined by the application of suitable statistical procedures
where appropriate.”
21 CFR 211.110 (b)
“Where appropriate, each manufacturer shall establish and maintain
procedures for identifying valid statistical techniques required for
establishing, controlling, and verifying the acceptability of process capability
and product characteristics.”
21 CFR 820.250 (a)
7
GHTF Process Validation Guidance for Medical
Device Manufacturers
0. Introduction
1. Purpose and scope
2. Definitions
3. Processes that should be validated
4. Statistical methods and tools for process validation – Appendix A
5. Conduct of a validation – Getting started, Protocol Development, IQ,
OQ, PQ, Final report
6. Maintain a state of validation – Monitor and Control and Revalidation
7. Use of historical data in process validation
8. Summary of activities
Annexes:
A. Statistical methods and tools for process validation
B. Example validation
8
Statistical Methods and Tools for Process Validation
Listed in GHTF Guidance, Annex A
Acceptance Sampling Plan
Analysis of Means
Analysis of Variance
Capability Study
Challenge Test
Component Swapping Study
Control Chart
Design of Experiments
Dual Response Approach to Robust Design
Failure Modes and Effects Analysis
Fault Tree Analysis
Gauge R&R Study
Mistake Proofing Methods
Multi-variable Control Chart
Response Surface Study
Robust Design Methods
Robust Tolerance Analysis
Screening Experiment
Taguchi Methods
Tolerance Analysis
Variance Components Analysis
9
Applying Statistical Methods Throughout
Process Validation
Installation
Qualification
• Sample size calculations
• Hypothesis testing
• Data intervals
• MSA
Operational
Qualification
Performance
Qualification
• Ishikawa diagram
• FMEA
• DOE
• RSM
• SPC
• Process capability
• Robust Design Methods
• SPC
• Process capability
• FMEA
10
Applying Statistical Methods Throughout
Process Validation
Installation
Qualification
• Sample size calculations
• Hypothesis testing
• Data intervals
• MSA
Operational
Qualification
Performance
Qualification
• Ishikawa diagram
• FMEA
• DOE
• RSM
• SPC
• Process capability
• Robust Design Methods
• SPC
• Process capability
• FMEA
Application of
Statistical Methods in IQ
12
Installation Qualification
“Installation Qualification (IQ): establishing by objective
evidence that all key aspects of the process equipment and
ancillary system installation adhere to the manufacturer’s
approved specification and that the recommendations of the
supplier of the equipment are suitably considered.”
GHTF Guidance on Process Validation
13
Installation Qualification
“Each medical device manufacturer is ultimately
responsible for evaluating, challenging, and testing the
equipment and deciding whether the equipment is
suitable for use in the manufacture of a specific
device(s).”
GHTF Guidance on Process Validation
14
IQ for Heat Sealer
A new heat sealer will be installed, checked, and calibrated. This
installation qualification will ensure the average exhaust of
pressurized air in the clean room does not exceed the
requirements of 14 psi. Also, the heat sealer contains a device
which measures seal strength. As part of the IQ, ensure the
device provides accurate and precise measurements of seal
strength.
Confidence interval for the true mean (one-sided)
One-sample t-test (one-tailed)
Sample size considerations
Two-sample t-test and Equivalence (Comparability)
15
Point Estimators
You are using a sample from a larger population to estimate the
mean, variance, and standard deviation; you use these
estimators to describe your sample.
Because you are estimating the true (population) parameter
with a single value, this is called a point estimator.
If instead you used a range of values to estimate the true
parameter, this range is called an interval estimator.
16
Confidence Intervals
Confidence intervals treat the mean as the point estimate and
account for the variability associated with that point estimate with
a margin of error.
17
Hypothesis Testing
The null hypothesis (H0) is the statement about what you
assume about the population parameter.
 Usually, this is a statement that there is no difference.
The alternate hypothesis (Ha) is the statement about what you
prove about the population parameter.
 Usually, this is a statement that there is a difference.
18
Hypothesis Testing
Does the seal strength equal 6.5?
Is the seal strength the same for Supplier A and B?
Is the seal strength the same for each size pouch (small, medium,
large)?
Does the supplier effect depend on the size of the pouch?
Do different levels of time, temperature, pressure, and rate affect
the seal strength?
19
One-sample t-test
H0: µ > 14 the true mean is greater than 14
Ha: µ < 14 the true mean is less than 14
α = 0.05 95% confidence
t-stat =
p-value =
20
Types of Errors
Did you make the right decision?
The probability of a Type I error is α.
The probability of a Type II error is β.
The power of the test is 1- β.
True
Conclude H0 Ha
H0
CORRECT
Type II error
Ha Type I error
CORRECT
21
Power
Power is the ability to detect differences that actually exist.
Power depends on:
• Sample size (n)
• α
• Difference to detect (δ) or effect size
• Standard deviation (σ)
5.5 6.5
22
Using an alpha level of 0.05, a standard
deviation of 1.0, a difference to detect of 0.5,
and a power of (at least) 80%, determine an
appropriate sample size.
Power and Sample Size
22
23
One-sample t-test
Using the randomly generated data, determine if
the true average exhaust of pressurized air in the
clean room is less than the requirement of 14 psi.
H0: µ > 14 the true mean is greater than 14
Ha: µ < 14 the true mean is less than 14
α = 0.05 95% confidence
t-stat =
p-value =
One-sided (95%) confidence interval:
(µ < )
Conclusion:
24
Using the randomly generated data, determine
if the true average exhaust of pressurized air in
the clean room is less than the requirement of
14 psi.
One sample t-test
24
25
Two-Sample t Test
H0: µA = µB The means are equal.
Ha: µA ≠ µB The means are different.
α = 0.05 95% confidence
t stat =
p-value =
t Test
Reactor B-Reactor A
Assuming equal variances
Difference
Std Err Dif
Upper CL Dif
Lower CL Dif
Confidence
-16.272
1.858
-12.465
-20.079
0.95
t Ratio
DF
Prob > |t|
Prob > t
Prob < t
-8.75575
28
<.0001*
1.0000
<.0001*
26
Two-Sample t Test
H0: µA = µB The means are equal.
Ha: µA ≠ µB The means are different.
α = 0.05 95% confidence
t stat = -8.756
p-value = <0.0001
t Test
Reactor B-Reactor A
Assuming equal variances
Difference
Std Err Dif
Upper CL Dif
Lower CL Dif
Confidence
-16.272
1.858
-12.465
-20.079
0.95
t Ratio
DF
Prob > |t|
Prob > t
Prob < t
-8.75575
28
<.0001*
1.0000
<.0001*
27
Equivalence Testing
The t test can conclude only that two sample means are
different. It cannot be used to show that the means are
the same.
An equivalence test reverses the null and alternative
hypotheses from the t test. If the result of an equivalence
test is significant, then the conclusion is that the two
means are practically equivalent.
28
Equivalence Testing
H0: |µA − µB| > δ The means differ by more than δ.
HA: |µA − µB| ≤ δ The means differ by at most δ.
α = 0.05 95% confidence
An equivalence test is performed by forming a confidence
interval around the difference in sample means. If this
confidence interval is entirely contained within a user-selected
interval (−δ, δ), then equivalence is concluded.
 Check whether the 90% CI formed around xA − xB is
contained within the interval (−δ, δ).
 A test size of α constructs a (1 − 2α) confidence interval
because two different comparisons are being performed
(against the lower and upper sides of the CI).
 The selection of δ is subjective and depends on subject-
matter expertise.
29
Equivalence Margin
Selection of the equivalence criteria (δ) is the key to the
outcome of similarity.
Reference: Tsong, Yi, and OB CMC Analytical Biosimilar Method Development Team (Meiyu
Shen, Cassie Xiaoyu Dong). 2015. Development of Statistical Approaches for Analytical
Biosimilarity Evaluation [PowerPoint]. DIA/FDA Statistics Forum.
30
Using the randomly generated data, determine
if two products are comparable (practically
equivalent).
Two Sample t-test and
Equivalence
30
Application of
Statistical Methods in OQ
32
Operational Qualification
“Operational Qualification (OQ): establishing by
objective evidence process control limits and action levels
which result in product that meets all predetermined
requirements.”
GHTF Guidance on Process Validation
33
Operational Qualification
“In this phase the process parameters should be challenged
to assure that they will result in a product that meets all
defined requirements under all anticipated conditions of
manufacturing, i.e., worst case testing. During routine
production and process control, it is desirable to measure
process parameters and/or product characteristics to allow
for the adjustment of the manufacturing process at various
action level(s) and maintain a state of control. These action
levels should be evaluated, established and documented
during process validation to determine the robustness of the
process and ability to avoid approaching ‘worst case
conditions.’ ”
GHTF Guidance on Process Validation
34
GHTF Process Validation Guidance for Medical Device
Manufacturers
[Considerations include] “Potential failure modes, action
levels and worst case conditions (Failure Modes and Effects
Analysis, Fault Tree Analysis)”
“The use of statistically valid techniques such as screening
experiments to establish key process parameters and
statistically designed experiments to optimize the process
can be used during this phase.”
35
OQ for Heat Sealer
First, determine potential key process parameters. Next, evaluate the
stability of these parameters; determine levels for screening experiments.
Then conduct both a screening experiment to set Installation optimal
conditions and a response surface study to center the process and
determine Installation process capability. Lastly, determine the sensitive
of the process to variations in these key process parameters and
establish process capability (Cpk > 1.0).
Cause-and-effect diagrams and FMEA
SPC
Screening experiment
Response surface study
Process capability
36
Factors using Ishikawa
The first step to establishing key process parameters is to
brainstorm which process parameters (factors ) may
‘cause’ an ‘effect’ on seal strength. A key quality tool to
accomplish this is a cause-and-effect diagram (also
known as a Ishikawa or fishbone diagram).
37
Factors using FMEA
The next step is to prioritize which process
parameters/factors to include in your experiments. Both
Failure Modes and Effects Analysis (FMEA) and Fault
Tree Analysis can be used to accomplish this.
38
FMEA and FTA
“An FMEA is a systematic analysis of the potential failure
modes. It includes the identification of possible failure
modes, determination of the potential causes and
consequences and an analysis of the associated
risk…FMEA can be performed on both the product and
the process. Typically, an FMEA is performed at the
component level, starting with potential failures and then
tracing up to the consequences. This is a bottoms up
approach. A variation is a Fault Tree Analysis, which
starts with possible consequences and traces down to the
potential causes.”
GHTF Guidance on Process Validation
39
FMEA
During FMEA brainstorming sessions, the following
ratings for Severity (Sev), Probability of Occurrence
(Occ), and the Probability of Detection (Det) are
determined. The Risk Priority Number (RPN) is
computed as:
RPN = Sev * Occ * Det
Item/Function
Potential Failure
Model
Potential Effect(s) of
Failure Severity
Potential Cause(s) of
Failure Occurrence
Current Design
Controls Detectability RPN
Platen Platen too hot Seal Strength too
low
10
Temp setting too
high 5 1
Platen defective 3 3
Platen too cool Seal Strength too
low
10
Temp setting too
high 5 1
Platen defective 3 3
40
Control Charts
“Control charts are used to detect changes in the process. A sample, typically
consisting of 5 consecutive units, is selected periodically. The average and
range of each sample is calculated and plotted. The plot of the averages is
used to determine if the process average changes. The plot of the ranges is
used to determine if the process variation changes. To aid in determining if a
change has occurred, control limits are calculated and added to the plots. The
control limits represent the maximum amount that the average or range should
vary if the process does not change. A point outside the control limits indicates
the process has changed. When a change is identified by the control chart, an
investigation should be made as to the cause of the change. Control charts help
identify key input variables causing the process to shift and aid in reduction of
the variation. Control charts are also used as part of a capability study to
demonstrate that the process is stable or consistent.”
- GHTF Guidance on Process Validation
41
Common Control Charts
Variables charts
 XBar
 R
 I
 MR
Attribute charts
 p
 np
 c
 u
42
XBar and R Chart
43
I & MR chart
44
Nelson Control Rules
*Taken from JMP 8.0.2 documentation.
45
Design of Experiments (DOE)
“The term designed experiment is a general term that
encompasses screening experiments, response surface
studies, and analysis of variance. In general, a designed
experiment involves purposely changing one or more
inputs and measuring the resulting effect on one or more
outputs.”
GHTF Guidance on Process Validation
46
DOE for 2-Level Process Parameters
DOE allows you to detect the significance of main effects as well as their interactions.
Time Press
1
2
3
4
- 1
+1
- 1
+1
- 1
- 1
+1
+1
+1
- 1
- 1
+1
Time *
Press
Seal
Strength
5.7
6.3
7.0
7.5
+
_
_
Time
+
Press
47
DOE for 2-Level Process Parameters
The benefits of designed experiments increases as the number of key
process parameters are added to the design. Add Temperature to the
design.
+
_ Temp
_
_
+
Time
+
Press
48
DOE for 2-Level Process Parameters
The benefits of designed experiments increases as the number of key
process parameters are added to the design. Add Rate to the design.
+
_
Press
Temp
_
_
+
Time
+
−
Rate
+
+
_
_
_
+
Time
+
49
Screening Experiment
“A screening experiment is a special type of designed
experiment whose primary purpose is to identify the key
input variables. Screen experiments are also referred to as
fractional factorial experiments...”
` GHTF Guidance on Process Validation
50
Screening Experiment
Fractional factorial experiments give up information about some of all
interactions in favor of examining more parameters. For the heat sealer, we
may want to know whether Time, Temperature, Pressure, or Rate has the
largest effect on Seal Strength. A 24 full-factorial design will have 16 runs. A
half-fraction factorial will have 8 runs.
Temp Press
1
2
3
4
5
6
7
8
- 1
+1
+1
- 1
+1
- 1
- 1
+1
- 1
+1
- 1
+1
- 1
+1
- 1
+1
- 1
- 1
+1
+1
- 1
- 1
+1
+1
Time Rate
- 1
- 1
- 1
- 1
+1
+1
+1
+1
51
This demonstration illustrates how to design
and analyze a screening design with Seal
Strength as the response and Time,
Temperature, Pressure, and Rate as the
factors. For Seal Strength, Match a Target of
6.5 (specification is 5.5 – 7.5).
Screening Designs
51
52
Response Surface Study
“A response surface study is a special type of designed
experiment whose purpose is to model the relationship
between the key input variables and the outputs.
Performing a response surface study involved running the
process at different settings for the inputs, called trials,
and measuring the resulting outputs. An equation can be
fit to the data to model the effect of the inputs on the
outputs. This equation can then be used to find optimal
targets...To ensure that only key input variables are
included in the study, a screening experiment is
frequently performed first.”
GHTF Guidance on Process Validation
53
Central Composite Design
A Central Composite Design (CCD) is a widely-used response
surface design.
Adds axial runs to the initial design.
Each factor in the design has 5 levels.
Each (added) experimental run has one factor at its axial value
and all others at 0.
+
_ Temp
_
_
+
Time
+
Press
54
This demonstration illustrates how to design
and analyze a CCD. What are your optimal
settings to match a Seal Strength of 6.5?
Run confirmation runs at the process settings to
determine Installation process capability.
Response Surface Design
54
55
Capability Study
“Capability studies are performed to evaluate the ability of a
process to consistently meet a specification. A capability study is
performed by selecting a small number of units periodically over
time. Each period of time is called a subgroup. For each
subgroup, the average and range is calculated. The averages and
ranges are plotted over time using a control chart to determine if
the process is stable or consistent over time. If so, the samples
are then combined to determine whether the process is
adequately centered and the variation is sufficiently small. This is
accomplished by calculating capability indexes. The most
commonly used capability indices are Cp and Cpk. If acceptable
values are obtained, the process consistently produces product
that meets the specification limits. Capability studies are
frequently used towards the end of validation to demonstrate that
the outputs consistently meet the specifications.”
GHTF Guidance on Process Validation
56
Is the Process Capable?
The most commonly used capability index is Cpk.
Example:
LSL USL
57
Is the Process Capable?
The most commonly used capability index is Cpk.
Example:
LSL USL
58
Process Capability
LSL USL LSL USL
Cpk = 1.0 Cpk = 2.0
When Cpk = 1,
27/10,000 results
will fall outside of
the specification.
When Cpk = 2,
2/1,000,000,000
results will fall outside
of the specification.
59
This demonstration illustrates the use of
confirmation runs to determine if your process
is capable (Cpk > 1.0).
Process Capability
59
60
This demonstration illustrates the use of
confirmation runs to determine if your process
is capable at:
a. Optimal settings
b. All low settings
c. All high settings
Determine the Cpk for each of the three settings.
Process Capability
60
Application of
Statistical Methods in PQ
62
Performance Qualification
“Performance Qualification (OQ): establishing by
objective evidence that the process, under anticipated
conditions, consistently produces a product which meets all
predetermined requirements.”
GHTF Guidance on Process Validation
63
Performance Qualification
“In this phase the key objective is to demonstrate the
process will consistently produce acceptable product under
normal operating conditions.’”
GHTF Guidance on Process Validation
64
PQ for Heat Sealer
In IQ, we ensured the heat sealer was installed correctly. In OQ,
we conducted tests to ensure the seal strength would meet the
pre-determined specifications under all manufacturing conditions.
In PQ, we want to demonstrate process consistency under normal
operating conditions. In order to accomplish this, we need to test
seal strength for an extended period of time; we need to
determine if our process is stable and capable. We would also like
to evaluate if our process is centered - how our process average
compares to the target.
SPC
Process Capability
65
This demonstration illustrates the use of
process control and capability during PQ.
Process Control & Capability
65
Adsurgo provides direct engagement consulting services
and training workshops focused on the use of analytics.
Our passion is for solving interesting, challenging, and
meaningful problems in collaborative, team-based
engagements with our clients.
W. Heath Rushing
Principal Consultant
206-369-5541
Heath.Rushing@adsurgo.com
Vital QMS Process Validation Statistics - OMTEC 2018

More Related Content

PDF
Operations: Top Reasons for Long Lead Times and What to Do About Them
PDF
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
PDF
Regulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
PDF
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
PDF
Leverage Computational Modeling and Simulation for Device Design - OMTEC 2017
PDF
Avoid Post-M&A Supply Chain Surprises - OMTEC 2017
PDF
Leveraging Data to Develop, Execute and Exceed the Expectations of Your Regu...
PDF
Design Controls: Building Objective Evidence and Process Architecture to Mee...
Operations: Top Reasons for Long Lead Times and What to Do About Them
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
Regulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
Leverage Computational Modeling and Simulation for Device Design - OMTEC 2017
Avoid Post-M&A Supply Chain Surprises - OMTEC 2017
Leveraging Data to Develop, Execute and Exceed the Expectations of Your Regu...
Design Controls: Building Objective Evidence and Process Architecture to Mee...

What's hot (20)

PDF
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
PDF
Modernize the Orthopaedic Supply Chain: A Surgeon’s View
PDF
How to Make Postmarket Surveillance More Cost Effective
PDF
Maximizing Use of Your Supplier Scorecard - OMTEC 2018
PDF
Additive Manufacturing - Design Considerations Rapid Fire - OMTEC 2018
PDF
CAPA: Using Risk-Based Decision-Making Toward Closure
PDF
How to Assess New Technology - OMTEC 2017
PDF
What do you do when regulatory requirements exceed that of reasonable enginee...
PDF
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
PDF
The Medical Device Milestone Map
PDF
Process Analytical Technology, Quality by Design & Pharmacogenomics
PDF
Pharmaceutical Product &amp; Process Design &amp; Quality
PDF
ISO20072: the device developer's perspective | Insight, issue 5
PPT
2004 4052 b1-09_Hussain-Arden-UK-Presentation
PDF
Systems Engineering and Requirements Management in Medical Device Product Dev...
PDF
What Is It? Product Development vs. Product Management
PPTX
Medical Device Development - Concept to Commercialization | Jahnavi Lokre | L...
PDF
Managing Reliability Expectations & Warranty Costs in Medical Electronics
PDF
Sharing a New Ideal: How Tomorrow’s Understaffed, Multi-Site Lab Organization...
PDF
Shedding Some Light on the Insights Lurking in the PMA Database
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
Modernize the Orthopaedic Supply Chain: A Surgeon’s View
How to Make Postmarket Surveillance More Cost Effective
Maximizing Use of Your Supplier Scorecard - OMTEC 2018
Additive Manufacturing - Design Considerations Rapid Fire - OMTEC 2018
CAPA: Using Risk-Based Decision-Making Toward Closure
How to Assess New Technology - OMTEC 2017
What do you do when regulatory requirements exceed that of reasonable enginee...
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
The Medical Device Milestone Map
Process Analytical Technology, Quality by Design & Pharmacogenomics
Pharmaceutical Product &amp; Process Design &amp; Quality
ISO20072: the device developer's perspective | Insight, issue 5
2004 4052 b1-09_Hussain-Arden-UK-Presentation
Systems Engineering and Requirements Management in Medical Device Product Dev...
What Is It? Product Development vs. Product Management
Medical Device Development - Concept to Commercialization | Jahnavi Lokre | L...
Managing Reliability Expectations & Warranty Costs in Medical Electronics
Sharing a New Ideal: How Tomorrow’s Understaffed, Multi-Site Lab Organization...
Shedding Some Light on the Insights Lurking in the PMA Database
Ad

Similar to Vital QMS Process Validation Statistics - OMTEC 2018 (20)

PDF
RM&IPR M4.pdfResearch Methodolgy & Intellectual Property Rights Series 4
PDF
IVT 2016 June - Stat Tools Binary Data
PDF
ecir2019tutorial
PDF
ecir2019tutorial-finalised
PDF
WSDM2019tutorial
PDF
Hypothesis testing
PPTX
Hypothesis Test _One-sample t-test, Z-test, Proportion Z-test
PDF
Data Analysis using Statistics and Hypothesis Testing in Quantitative Studies...
PDF
8. testing of hypothesis for variable &amp; attribute data
PDF
Designing Test Collections for Comparing Many Systems
PPTX
HypothesisTesting.pptx
DOCX
Hypothesis Testing Definitions A statistical hypothesi.docx
PDF
What are the different type of validation
PDF
sigir2018tutorial
PPTX
hypothesis.pptx
PPTX
Confidence intervals, hypothesis testing and statistical tests of significanc...
PPTX
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
PPTX
Basics of Hypothesis Testing
PPTX
Session 12_Hypothesis Testing-Single Sample Tests.pptx
PPTX
bio statistical tools of process validation
RM&IPR M4.pdfResearch Methodolgy & Intellectual Property Rights Series 4
IVT 2016 June - Stat Tools Binary Data
ecir2019tutorial
ecir2019tutorial-finalised
WSDM2019tutorial
Hypothesis testing
Hypothesis Test _One-sample t-test, Z-test, Proportion Z-test
Data Analysis using Statistics and Hypothesis Testing in Quantitative Studies...
8. testing of hypothesis for variable &amp; attribute data
Designing Test Collections for Comparing Many Systems
HypothesisTesting.pptx
Hypothesis Testing Definitions A statistical hypothesi.docx
What are the different type of validation
sigir2018tutorial
hypothesis.pptx
Confidence intervals, hypothesis testing and statistical tests of significanc...
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
Basics of Hypothesis Testing
Session 12_Hypothesis Testing-Single Sample Tests.pptx
bio statistical tools of process validation
Ad

More from April Bright (20)

PDF
The Future of Digital Health and Wearables in Orthopedicsrables
PPTX
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
PDF
Innovation in Orthopedics: Surgeon Perspectives
PDF
Antimicrobial Coatings: The Research and Regulatory Perspective
PDF
Leverage These Effective Communication Skills to Get Your Message Across
PDF
Joint Replacement: The Current and Future Impact of Coatings
PDF
Engineers: Practical Application of Project Management Principles
PDF
The Future of Orthobiologics in Trauma Procedures
PDF
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive Manufacturing
PDF
How to Influence People: The Value of Employee Engagement
PDF
Real-World Evidence: The Future of Data Generation and Usage
PDF
Orthopedic Coatings: Predictions for 2025
PDF
Engineers: Apply Automation to Increase Quality, Speed to Market
PDF
Unique Device Identification: Manufacturer, Hospital and Global Implications
PDF
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
PDF
Considerations for Your Minimally Invasive Device - OMTEC 2018
PDF
Additive Manufacturing - Powder Considerations Rapid Fire - OMTEC 2018
PDF
Additive Manufacturing Discussion Panel – Developing a Roadmap for Regulatory...
PDF
Additive Manufacturing - Cleaning: Guidance for Removing Residual Powders - O...
PDF
Coatings: The Power of Bone Integration to Aid Recovery - OMTEC 2018
The Future of Digital Health and Wearables in Orthopedicsrables
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
Innovation in Orthopedics: Surgeon Perspectives
Antimicrobial Coatings: The Research and Regulatory Perspective
Leverage These Effective Communication Skills to Get Your Message Across
Joint Replacement: The Current and Future Impact of Coatings
Engineers: Practical Application of Project Management Principles
The Future of Orthobiologics in Trauma Procedures
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive Manufacturing
How to Influence People: The Value of Employee Engagement
Real-World Evidence: The Future of Data Generation and Usage
Orthopedic Coatings: Predictions for 2025
Engineers: Apply Automation to Increase Quality, Speed to Market
Unique Device Identification: Manufacturer, Hospital and Global Implications
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
Considerations for Your Minimally Invasive Device - OMTEC 2018
Additive Manufacturing - Powder Considerations Rapid Fire - OMTEC 2018
Additive Manufacturing Discussion Panel – Developing a Roadmap for Regulatory...
Additive Manufacturing - Cleaning: Guidance for Removing Residual Powders - O...
Coatings: The Power of Bone Integration to Aid Recovery - OMTEC 2018

Recently uploaded (20)

PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
ACID BASE management, base deficit correction
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
1 General Principles of Radiotherapy.pptx
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Note on Abortion.pptx for the student note
PPTX
CME 2 Acute Chest Pain preentation for education
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
Respiratory drugs, drugs acting on the respi system
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
post stroke aphasia rehabilitation physician
PPTX
Acid Base Disorders educational power point.pptx
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
MENTAL HEALTH - NOTES.ppt for nursing students
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
ACID BASE management, base deficit correction
History and examination of abdomen, & pelvis .pptx
1 General Principles of Radiotherapy.pptx
Neuropathic pain.ppt treatment managment
Note on Abortion.pptx for the student note
CME 2 Acute Chest Pain preentation for education
ASRH Presentation for students and teachers 2770633.ppt
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
CT Anatomy for Radiotherapy.pdf eryuioooop
Respiratory drugs, drugs acting on the respi system
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
post stroke aphasia rehabilitation physician
Acid Base Disorders educational power point.pptx
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer

Vital QMS Process Validation Statistics - OMTEC 2018

  • 2. Vital QMS Process Validation Statistics W. Heath Rushing Principal Consultant 206-369-5541 Heath.Rushing@adsurgo.com
  • 3. 3 Contents 1. Introduction 2. Overview 3. Application of Statistical Methods: - Installation Qualification (IQ) - Operational Qualification (OQ) - Performance Qualification (PQ)
  • 4. 4 Why are you here? According to the Quality System Regulation (QSR), “Where appropriate, each manufacturer shall establish and maintain procedures for identifying valid statistical techniques required for establishing, controlling, verifying the acceptability of process capability and product characteristics.” Although there are many statistical methods that may be applied to satisfy this portion of the QSR, there are some commonly accepted methods that all companies can and should be using to develop acceptance criteria, to ensure accurate and precise measurement systems, to fully characterize manufacturing processes, to monitor and control process results and to select an appropriate number of samples.
  • 6. 6 Statistical Techniques “Valid in-process specifications for such characteristics shall be consistent with drug product final specifications and shall be derived from previous acceptable process average and process variability estimates where possible and determined by the application of suitable statistical procedures where appropriate.” 21 CFR 211.110 (b) “Where appropriate, each manufacturer shall establish and maintain procedures for identifying valid statistical techniques required for establishing, controlling, and verifying the acceptability of process capability and product characteristics.” 21 CFR 820.250 (a)
  • 7. 7 GHTF Process Validation Guidance for Medical Device Manufacturers 0. Introduction 1. Purpose and scope 2. Definitions 3. Processes that should be validated 4. Statistical methods and tools for process validation – Appendix A 5. Conduct of a validation – Getting started, Protocol Development, IQ, OQ, PQ, Final report 6. Maintain a state of validation – Monitor and Control and Revalidation 7. Use of historical data in process validation 8. Summary of activities Annexes: A. Statistical methods and tools for process validation B. Example validation
  • 8. 8 Statistical Methods and Tools for Process Validation Listed in GHTF Guidance, Annex A Acceptance Sampling Plan Analysis of Means Analysis of Variance Capability Study Challenge Test Component Swapping Study Control Chart Design of Experiments Dual Response Approach to Robust Design Failure Modes and Effects Analysis Fault Tree Analysis Gauge R&R Study Mistake Proofing Methods Multi-variable Control Chart Response Surface Study Robust Design Methods Robust Tolerance Analysis Screening Experiment Taguchi Methods Tolerance Analysis Variance Components Analysis
  • 9. 9 Applying Statistical Methods Throughout Process Validation Installation Qualification • Sample size calculations • Hypothesis testing • Data intervals • MSA Operational Qualification Performance Qualification • Ishikawa diagram • FMEA • DOE • RSM • SPC • Process capability • Robust Design Methods • SPC • Process capability • FMEA
  • 10. 10 Applying Statistical Methods Throughout Process Validation Installation Qualification • Sample size calculations • Hypothesis testing • Data intervals • MSA Operational Qualification Performance Qualification • Ishikawa diagram • FMEA • DOE • RSM • SPC • Process capability • Robust Design Methods • SPC • Process capability • FMEA
  • 12. 12 Installation Qualification “Installation Qualification (IQ): establishing by objective evidence that all key aspects of the process equipment and ancillary system installation adhere to the manufacturer’s approved specification and that the recommendations of the supplier of the equipment are suitably considered.” GHTF Guidance on Process Validation
  • 13. 13 Installation Qualification “Each medical device manufacturer is ultimately responsible for evaluating, challenging, and testing the equipment and deciding whether the equipment is suitable for use in the manufacture of a specific device(s).” GHTF Guidance on Process Validation
  • 14. 14 IQ for Heat Sealer A new heat sealer will be installed, checked, and calibrated. This installation qualification will ensure the average exhaust of pressurized air in the clean room does not exceed the requirements of 14 psi. Also, the heat sealer contains a device which measures seal strength. As part of the IQ, ensure the device provides accurate and precise measurements of seal strength. Confidence interval for the true mean (one-sided) One-sample t-test (one-tailed) Sample size considerations Two-sample t-test and Equivalence (Comparability)
  • 15. 15 Point Estimators You are using a sample from a larger population to estimate the mean, variance, and standard deviation; you use these estimators to describe your sample. Because you are estimating the true (population) parameter with a single value, this is called a point estimator. If instead you used a range of values to estimate the true parameter, this range is called an interval estimator.
  • 16. 16 Confidence Intervals Confidence intervals treat the mean as the point estimate and account for the variability associated with that point estimate with a margin of error.
  • 17. 17 Hypothesis Testing The null hypothesis (H0) is the statement about what you assume about the population parameter.  Usually, this is a statement that there is no difference. The alternate hypothesis (Ha) is the statement about what you prove about the population parameter.  Usually, this is a statement that there is a difference.
  • 18. 18 Hypothesis Testing Does the seal strength equal 6.5? Is the seal strength the same for Supplier A and B? Is the seal strength the same for each size pouch (small, medium, large)? Does the supplier effect depend on the size of the pouch? Do different levels of time, temperature, pressure, and rate affect the seal strength?
  • 19. 19 One-sample t-test H0: µ > 14 the true mean is greater than 14 Ha: µ < 14 the true mean is less than 14 α = 0.05 95% confidence t-stat = p-value =
  • 20. 20 Types of Errors Did you make the right decision? The probability of a Type I error is α. The probability of a Type II error is β. The power of the test is 1- β. True Conclude H0 Ha H0 CORRECT Type II error Ha Type I error CORRECT
  • 21. 21 Power Power is the ability to detect differences that actually exist. Power depends on: • Sample size (n) • α • Difference to detect (δ) or effect size • Standard deviation (σ) 5.5 6.5
  • 22. 22 Using an alpha level of 0.05, a standard deviation of 1.0, a difference to detect of 0.5, and a power of (at least) 80%, determine an appropriate sample size. Power and Sample Size 22
  • 23. 23 One-sample t-test Using the randomly generated data, determine if the true average exhaust of pressurized air in the clean room is less than the requirement of 14 psi. H0: µ > 14 the true mean is greater than 14 Ha: µ < 14 the true mean is less than 14 α = 0.05 95% confidence t-stat = p-value = One-sided (95%) confidence interval: (µ < ) Conclusion:
  • 24. 24 Using the randomly generated data, determine if the true average exhaust of pressurized air in the clean room is less than the requirement of 14 psi. One sample t-test 24
  • 25. 25 Two-Sample t Test H0: µA = µB The means are equal. Ha: µA ≠ µB The means are different. α = 0.05 95% confidence t stat = p-value = t Test Reactor B-Reactor A Assuming equal variances Difference Std Err Dif Upper CL Dif Lower CL Dif Confidence -16.272 1.858 -12.465 -20.079 0.95 t Ratio DF Prob > |t| Prob > t Prob < t -8.75575 28 <.0001* 1.0000 <.0001*
  • 26. 26 Two-Sample t Test H0: µA = µB The means are equal. Ha: µA ≠ µB The means are different. α = 0.05 95% confidence t stat = -8.756 p-value = <0.0001 t Test Reactor B-Reactor A Assuming equal variances Difference Std Err Dif Upper CL Dif Lower CL Dif Confidence -16.272 1.858 -12.465 -20.079 0.95 t Ratio DF Prob > |t| Prob > t Prob < t -8.75575 28 <.0001* 1.0000 <.0001*
  • 27. 27 Equivalence Testing The t test can conclude only that two sample means are different. It cannot be used to show that the means are the same. An equivalence test reverses the null and alternative hypotheses from the t test. If the result of an equivalence test is significant, then the conclusion is that the two means are practically equivalent.
  • 28. 28 Equivalence Testing H0: |µA − µB| > δ The means differ by more than δ. HA: |µA − µB| ≤ δ The means differ by at most δ. α = 0.05 95% confidence An equivalence test is performed by forming a confidence interval around the difference in sample means. If this confidence interval is entirely contained within a user-selected interval (−δ, δ), then equivalence is concluded.  Check whether the 90% CI formed around xA − xB is contained within the interval (−δ, δ).  A test size of α constructs a (1 − 2α) confidence interval because two different comparisons are being performed (against the lower and upper sides of the CI).  The selection of δ is subjective and depends on subject- matter expertise.
  • 29. 29 Equivalence Margin Selection of the equivalence criteria (δ) is the key to the outcome of similarity. Reference: Tsong, Yi, and OB CMC Analytical Biosimilar Method Development Team (Meiyu Shen, Cassie Xiaoyu Dong). 2015. Development of Statistical Approaches for Analytical Biosimilarity Evaluation [PowerPoint]. DIA/FDA Statistics Forum.
  • 30. 30 Using the randomly generated data, determine if two products are comparable (practically equivalent). Two Sample t-test and Equivalence 30
  • 32. 32 Operational Qualification “Operational Qualification (OQ): establishing by objective evidence process control limits and action levels which result in product that meets all predetermined requirements.” GHTF Guidance on Process Validation
  • 33. 33 Operational Qualification “In this phase the process parameters should be challenged to assure that they will result in a product that meets all defined requirements under all anticipated conditions of manufacturing, i.e., worst case testing. During routine production and process control, it is desirable to measure process parameters and/or product characteristics to allow for the adjustment of the manufacturing process at various action level(s) and maintain a state of control. These action levels should be evaluated, established and documented during process validation to determine the robustness of the process and ability to avoid approaching ‘worst case conditions.’ ” GHTF Guidance on Process Validation
  • 34. 34 GHTF Process Validation Guidance for Medical Device Manufacturers [Considerations include] “Potential failure modes, action levels and worst case conditions (Failure Modes and Effects Analysis, Fault Tree Analysis)” “The use of statistically valid techniques such as screening experiments to establish key process parameters and statistically designed experiments to optimize the process can be used during this phase.”
  • 35. 35 OQ for Heat Sealer First, determine potential key process parameters. Next, evaluate the stability of these parameters; determine levels for screening experiments. Then conduct both a screening experiment to set Installation optimal conditions and a response surface study to center the process and determine Installation process capability. Lastly, determine the sensitive of the process to variations in these key process parameters and establish process capability (Cpk > 1.0). Cause-and-effect diagrams and FMEA SPC Screening experiment Response surface study Process capability
  • 36. 36 Factors using Ishikawa The first step to establishing key process parameters is to brainstorm which process parameters (factors ) may ‘cause’ an ‘effect’ on seal strength. A key quality tool to accomplish this is a cause-and-effect diagram (also known as a Ishikawa or fishbone diagram).
  • 37. 37 Factors using FMEA The next step is to prioritize which process parameters/factors to include in your experiments. Both Failure Modes and Effects Analysis (FMEA) and Fault Tree Analysis can be used to accomplish this.
  • 38. 38 FMEA and FTA “An FMEA is a systematic analysis of the potential failure modes. It includes the identification of possible failure modes, determination of the potential causes and consequences and an analysis of the associated risk…FMEA can be performed on both the product and the process. Typically, an FMEA is performed at the component level, starting with potential failures and then tracing up to the consequences. This is a bottoms up approach. A variation is a Fault Tree Analysis, which starts with possible consequences and traces down to the potential causes.” GHTF Guidance on Process Validation
  • 39. 39 FMEA During FMEA brainstorming sessions, the following ratings for Severity (Sev), Probability of Occurrence (Occ), and the Probability of Detection (Det) are determined. The Risk Priority Number (RPN) is computed as: RPN = Sev * Occ * Det Item/Function Potential Failure Model Potential Effect(s) of Failure Severity Potential Cause(s) of Failure Occurrence Current Design Controls Detectability RPN Platen Platen too hot Seal Strength too low 10 Temp setting too high 5 1 Platen defective 3 3 Platen too cool Seal Strength too low 10 Temp setting too high 5 1 Platen defective 3 3
  • 40. 40 Control Charts “Control charts are used to detect changes in the process. A sample, typically consisting of 5 consecutive units, is selected periodically. The average and range of each sample is calculated and plotted. The plot of the averages is used to determine if the process average changes. The plot of the ranges is used to determine if the process variation changes. To aid in determining if a change has occurred, control limits are calculated and added to the plots. The control limits represent the maximum amount that the average or range should vary if the process does not change. A point outside the control limits indicates the process has changed. When a change is identified by the control chart, an investigation should be made as to the cause of the change. Control charts help identify key input variables causing the process to shift and aid in reduction of the variation. Control charts are also used as part of a capability study to demonstrate that the process is stable or consistent.” - GHTF Guidance on Process Validation
  • 41. 41 Common Control Charts Variables charts  XBar  R  I  MR Attribute charts  p  np  c  u
  • 42. 42 XBar and R Chart
  • 43. 43 I & MR chart
  • 44. 44 Nelson Control Rules *Taken from JMP 8.0.2 documentation.
  • 45. 45 Design of Experiments (DOE) “The term designed experiment is a general term that encompasses screening experiments, response surface studies, and analysis of variance. In general, a designed experiment involves purposely changing one or more inputs and measuring the resulting effect on one or more outputs.” GHTF Guidance on Process Validation
  • 46. 46 DOE for 2-Level Process Parameters DOE allows you to detect the significance of main effects as well as their interactions. Time Press 1 2 3 4 - 1 +1 - 1 +1 - 1 - 1 +1 +1 +1 - 1 - 1 +1 Time * Press Seal Strength 5.7 6.3 7.0 7.5 + _ _ Time + Press
  • 47. 47 DOE for 2-Level Process Parameters The benefits of designed experiments increases as the number of key process parameters are added to the design. Add Temperature to the design. + _ Temp _ _ + Time + Press
  • 48. 48 DOE for 2-Level Process Parameters The benefits of designed experiments increases as the number of key process parameters are added to the design. Add Rate to the design. + _ Press Temp _ _ + Time + − Rate + + _ _ _ + Time +
  • 49. 49 Screening Experiment “A screening experiment is a special type of designed experiment whose primary purpose is to identify the key input variables. Screen experiments are also referred to as fractional factorial experiments...” ` GHTF Guidance on Process Validation
  • 50. 50 Screening Experiment Fractional factorial experiments give up information about some of all interactions in favor of examining more parameters. For the heat sealer, we may want to know whether Time, Temperature, Pressure, or Rate has the largest effect on Seal Strength. A 24 full-factorial design will have 16 runs. A half-fraction factorial will have 8 runs. Temp Press 1 2 3 4 5 6 7 8 - 1 +1 +1 - 1 +1 - 1 - 1 +1 - 1 +1 - 1 +1 - 1 +1 - 1 +1 - 1 - 1 +1 +1 - 1 - 1 +1 +1 Time Rate - 1 - 1 - 1 - 1 +1 +1 +1 +1
  • 51. 51 This demonstration illustrates how to design and analyze a screening design with Seal Strength as the response and Time, Temperature, Pressure, and Rate as the factors. For Seal Strength, Match a Target of 6.5 (specification is 5.5 – 7.5). Screening Designs 51
  • 52. 52 Response Surface Study “A response surface study is a special type of designed experiment whose purpose is to model the relationship between the key input variables and the outputs. Performing a response surface study involved running the process at different settings for the inputs, called trials, and measuring the resulting outputs. An equation can be fit to the data to model the effect of the inputs on the outputs. This equation can then be used to find optimal targets...To ensure that only key input variables are included in the study, a screening experiment is frequently performed first.” GHTF Guidance on Process Validation
  • 53. 53 Central Composite Design A Central Composite Design (CCD) is a widely-used response surface design. Adds axial runs to the initial design. Each factor in the design has 5 levels. Each (added) experimental run has one factor at its axial value and all others at 0. + _ Temp _ _ + Time + Press
  • 54. 54 This demonstration illustrates how to design and analyze a CCD. What are your optimal settings to match a Seal Strength of 6.5? Run confirmation runs at the process settings to determine Installation process capability. Response Surface Design 54
  • 55. 55 Capability Study “Capability studies are performed to evaluate the ability of a process to consistently meet a specification. A capability study is performed by selecting a small number of units periodically over time. Each period of time is called a subgroup. For each subgroup, the average and range is calculated. The averages and ranges are plotted over time using a control chart to determine if the process is stable or consistent over time. If so, the samples are then combined to determine whether the process is adequately centered and the variation is sufficiently small. This is accomplished by calculating capability indexes. The most commonly used capability indices are Cp and Cpk. If acceptable values are obtained, the process consistently produces product that meets the specification limits. Capability studies are frequently used towards the end of validation to demonstrate that the outputs consistently meet the specifications.” GHTF Guidance on Process Validation
  • 56. 56 Is the Process Capable? The most commonly used capability index is Cpk. Example: LSL USL
  • 57. 57 Is the Process Capable? The most commonly used capability index is Cpk. Example: LSL USL
  • 58. 58 Process Capability LSL USL LSL USL Cpk = 1.0 Cpk = 2.0 When Cpk = 1, 27/10,000 results will fall outside of the specification. When Cpk = 2, 2/1,000,000,000 results will fall outside of the specification.
  • 59. 59 This demonstration illustrates the use of confirmation runs to determine if your process is capable (Cpk > 1.0). Process Capability 59
  • 60. 60 This demonstration illustrates the use of confirmation runs to determine if your process is capable at: a. Optimal settings b. All low settings c. All high settings Determine the Cpk for each of the three settings. Process Capability 60
  • 62. 62 Performance Qualification “Performance Qualification (OQ): establishing by objective evidence that the process, under anticipated conditions, consistently produces a product which meets all predetermined requirements.” GHTF Guidance on Process Validation
  • 63. 63 Performance Qualification “In this phase the key objective is to demonstrate the process will consistently produce acceptable product under normal operating conditions.’” GHTF Guidance on Process Validation
  • 64. 64 PQ for Heat Sealer In IQ, we ensured the heat sealer was installed correctly. In OQ, we conducted tests to ensure the seal strength would meet the pre-determined specifications under all manufacturing conditions. In PQ, we want to demonstrate process consistency under normal operating conditions. In order to accomplish this, we need to test seal strength for an extended period of time; we need to determine if our process is stable and capable. We would also like to evaluate if our process is centered - how our process average compares to the target. SPC Process Capability
  • 65. 65 This demonstration illustrates the use of process control and capability during PQ. Process Control & Capability 65
  • 66. Adsurgo provides direct engagement consulting services and training workshops focused on the use of analytics. Our passion is for solving interesting, challenging, and meaningful problems in collaborative, team-based engagements with our clients. W. Heath Rushing Principal Consultant 206-369-5541 Heath.Rushing@adsurgo.com